Necroptotic cell death mechanism has been identified as a relevant neurotoxic pathway in in vitro and in vivo models of ALS and the RIPK1- specific inhibitor Necrostatin-1 (Nec) was found to increase cell survival in both ALS models (Yuan et al., 2019). This evidence concerns the gene RIPK1 and amyotrophic lateral sclerosis.